NO912942L - Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. - Google Patents

Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.

Info

Publication number
NO912942L
NO912942L NO91912942A NO912942A NO912942L NO 912942 L NO912942 L NO 912942L NO 91912942 A NO91912942 A NO 91912942A NO 912942 A NO912942 A NO 912942A NO 912942 L NO912942 L NO 912942L
Authority
NO
Norway
Prior art keywords
vaccine
infection
liverability
drugs
preventive treatment
Prior art date
Application number
NO91912942A
Other languages
English (en)
Norwegian (no)
Other versions
NO912942D0 (no
Inventor
Sonia Louise Crameri
Michael Panaccio
Lachlan Robert Wilson
Gene Louise Wijffels
Terence William Spithill
Noel John Campbell
Catriona Mary Thompson
Jennifer Louise Sexton
Andrew Richard Milner
Graham Frank Mitshell
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Publication of NO912942D0 publication Critical patent/NO912942D0/no
Publication of NO912942L publication Critical patent/NO912942L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO91912942A 1989-01-31 1991-07-29 Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. NO912942L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ248189 1989-01-31
PCT/AU1990/000027 WO1990008819A1 (en) 1989-01-31 1990-01-31 Vaccine for the preventative treatment of infection of liver fluke in ruminants

Publications (2)

Publication Number Publication Date
NO912942D0 NO912942D0 (no) 1991-07-29
NO912942L true NO912942L (no) 1991-09-26

Family

ID=3773671

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912942A NO912942L (no) 1989-01-31 1991-07-29 Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.

Country Status (8)

Country Link
EP (1) EP0456662A4 (pt)
JP (1) JPH04507235A (pt)
AU (1) AU634754B2 (pt)
BR (1) BR9007070A (pt)
CA (1) CA2045663A1 (pt)
NO (1) NO912942L (pt)
NZ (1) NZ232327A (pt)
WO (1) WO1990008819A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657883A1 (pt) * 1990-02-07 1991-08-09 Transgene Sa
GB9018238D0 (en) * 1990-08-20 1990-10-03 Trudgett Alan G Liver fluke diagnostic system
PT666919E (pt) * 1992-10-21 2003-09-30 John Pius Dalton Vacina contendo uma protease de tiol
JPH07505787A (ja) * 1993-02-05 1995-06-29 ダラテク・プロプライエタリー・リミテッド ファスキオラ種から取得可能なポリペプチド類，およびワクチン，処置法およびそのｄｎａ配列
CA2172492A1 (en) * 1993-09-28 1995-04-06 Elza Nicole Theresia Meeusen Protective antigens against parasites
CN1061990C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(一)
CN1068334C (zh) * 1994-06-08 2001-07-11 北京医科大学 新型血吸虫疫苗肽(二)
CN1061991C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(三)
GB9612214D0 (en) * 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
CN105903007A (zh) * 2016-06-15 2016-08-31 青海大学 一种新型肝片吸虫多表位疫苗的设计、制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors

Also Published As

Publication number Publication date
NO912942D0 (no) 1991-07-29
EP0456662A4 (en) 1991-12-11
BR9007070A (pt) 1991-11-12
WO1990008819A1 (en) 1990-08-09
JPH04507235A (ja) 1992-12-17
AU634754B2 (en) 1993-03-04
NZ232327A (en) 1993-02-25
CA2045663A1 (en) 1990-08-01
AU5028390A (en) 1990-08-24
EP0456662A1 (en) 1991-11-21

Similar Documents

Publication Publication Date Title
AU4533589A (en) Skin test and test kit for aids
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
NO933126D0 (no) Loeselige ligander for cd40
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
NO912942L (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
EP0313378A3 (en) Methods and compositions for transient elimination of humoral immune antibodies
DE68907679D1 (de) Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweg-geschwuerkrankheiten.
ATE243750T1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
ES2058343T3 (es) Piridinas disubstituidas.
DE3751772D1 (de) Impfstoff zur behandlung von hsv
ES2088431T3 (es) Preparacion biologica y su utilizacion.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
Tu et al. Comparison of Naja naja siamensis and Naja naja atra venoms
EP0251460A3 (en) Method for producing hepatitis b virus core antigen (hbcag) in yeast
Gerenčer et al. Immunosuppression of in vivo and in vitro lymphocyte responses in swine induced by Trichinella spiralis or excretory-secretory antigens of the parasite
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE3784513D1 (de) Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse.
Sun et al. Effect of selenium in recovery of immunity damaged by H 2 O 2 and 60 Co radiation